ProShares Ultra Nasdaq Biotechnology Rating $47.12 -0.76 (-1.58%) Closing price 06/11/2025 03:58 PM EasternExtended Trading$47.12 0.00 (0.00%) As of 06/11/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.75Holdings in BIB have an aggregate rating of Moderate Buy based on 2,335 analyst ratings issued in the past year covering 250 companies (71.0% of the portfolio).BIB Aggregate Price Target$47.13High Prediction$47.13Average Prediction$47.13Low Prediction$47.13Holdings in BIB have an aggregate price target of $47.13 and a range of $47.13 to $47.13 covering 250 companies (71.0% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy2 Strong Buy rating(s)Buy118 Buy rating(s)Moderate Buy87 Moderate Buy rating(s)Hold38 Hold rating(s)Reduce5 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.03%GILDGilead Sciences$109.30-0.7%4.88 of 5 stars2.78$110.55 1.1%27Trending NewsAnalyst Revision5.78%AMGNAmgen$291.81-0.6%4.4581 of 5 stars2.38$309.22 6.0%24Positive NewsAnalyst Revision5.76%VRTXVertex Pharmaceuticals$452.44+0.2%4.5794 of 5 stars2.57$515.04 13.8%30Positive NewsAnalyst Revision4.05%REGNRegeneron Pharmaceuticals$518.60-0.9%4.8104 of 5 stars2.85$836.48 61.3%26Analyst ForecastAnalyst Revision3.24%AZNAstraZeneca$73.74-0.1%2.9329 of 5 stars3.13$85.00 15.3%8Positive News2.98%ALNYAlnylam Pharmaceuticals$298.58-1.3%4.1838 of 5 stars2.77$319.17 6.9%26Positive News1.49%BIIBBiogen$133.06-1.8%4.767 of 5 stars2.38$191.30 43.8%32Positive News1.43%ARGXargenx$574.96-0.1%3.5039 of 5 stars3.05$709.18 23.3%22Analyst Forecast1.16%SMMTSummit Therapeutics$19.58-11.3%2.954 of 5 stars2.92$35.09 79.2%12Trending NewsAnalyst ForecastAnalyst RevisionGap Down1.12%RPRXRoyalty Pharma$34.05+1.4%4.6836 of 5 stars3.25$47.33 39.0%4Positive NewsShort Interest ↑1.12%UTHRUnited Therapeutics$276.47-1.7%4.9942 of 5 stars2.69$393.08 42.2%13Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume1.11%SNYSanofi$49.70-0.4%3.4057 of 5 stars3.13$61.50 23.7%8Short Interest ↑1.02%INCYIncyte$68.85-1.7%4.3963 of 5 stars2.17$72.53 5.3%181.02%INSMInsmed$97.98+7.8%3.267 of 5 stars3.00$104.81 7.0%18Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.00%ILMNIllumina$87.54-0.5%4.9053 of 5 stars2.47$126.94 45.0%19Positive NewsAnalyst ForecastOptions Volume0.96%NBIXNeurocrine Biosciences$124.17-0.5%4.8648 of 5 stars2.86$162.00 30.5%22Analyst Revision0.92%EXELExelixis$41.43-2.6%4.3932 of 5 stars2.47$39.35 -5.0%190.83%BNTXBioNTech$105.46-1.3%2.8468 of 5 stars2.83$138.25 31.1%18Analyst Revision0.83%BMRNBioMarin Pharmaceutical$57.16-0.6%4.9304 of 5 stars2.74$93.45 63.5%23Positive NewsAnalyst Revision0.82%ONCBeigene$262.41-0.4%1.3376 of 5 stars3.00$319.00 21.6%6Trending NewsInsider Trade0.81%MRNAModerna$27.75+0.3%4.5161 of 5 stars2.04$53.58 93.1%23Trending News0.80%ASNDAscendis Pharma A/S$171.72-0.4%3.5456 of 5 stars3.00$217.73 26.8%15Analyst ForecastAnalyst Revision0.79%TEMTempus AI$70.78+2.0%1.6659 of 5 stars2.54$63.42 -10.4%13Trending NewsHigh Trading Volume0.79%VTRSViatris$8.98-0.7%2.508 of 5 stars1.80$10.40 15.8%50.69%MEDPMedpace$302.31-1.2%4.6777 of 5 stars2.23$349.30 15.5%13Positive News0.62%BPMCBlueprint Medicines$127.950.0%1.1376 of 5 stars2.32$129.35 1.1%22High Trading Volume0.61%ROIVRoivant Sciences$11.28-0.8%2.3598 of 5 stars3.00$17.50 55.1%40.58%RVMDRevolution Medicines$40.79-2.8%4.3054 of 5 stars3.00$67.08 64.5%120.56%BBIOBridgeBio Pharma$39.05-2.6%4.6128 of 5 stars2.92$57.36 46.9%12Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.52%JAZZJazz Pharmaceuticals$110.50-2.2%4.9667 of 5 stars2.92$184.00 66.5%13Analyst Forecast0.51%HALOHalozyme Therapeutics$53.85+0.1%4.8738 of 5 stars2.17$61.90 14.9%120.51%VRNAVerona Pharma$90.05+3.8%2.5029 of 5 stars3.10$87.44 -2.9%10Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.47%MDGLMadrigal Pharmaceuticals$294.34+4.3%4.3319 of 5 stars2.89$420.63 42.9%9Positive NewsAnalyst Revision0.45%GHGuardant Health$49.03-2.1%3.7787 of 5 stars3.05$53.29 8.7%21Insider Trade0.43%IONSIonis Pharmaceuticals$36.19-1.8%4.4045 of 5 stars2.65$56.67 56.6%200.42%AXSMAxsome Therapeutics$108.08-1.7%4.7492 of 5 stars3.06$172.80 59.9%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.39%ALKSAlkermes$31.20+0.5%4.2808 of 5 stars2.77$38.85 24.5%13Insider Trade0.39%NUVLNuvalent$76.91-3.2%2.1829 of 5 stars2.90$115.50 50.2%100.37%ADMAADMA Biologics$21.87+4.8%2.1667 of 5 stars3.25$24.25 10.9%4Insider TradeAnalyst Revision0.36%PCVXVaxcyte$35.44-4.7%2.7624 of 5 stars3.10$136.50 285.2%10Analyst Revision0.33%AKROAkero Therapeutics$52.96-2.9%3.7124 of 5 stars3.00$82.50 55.8%7Insider TradeOptions Volume0.33%RNAAvidity Biosciences$32.01-4.8%2.2694 of 5 stars3.07$67.33 110.4%15Trending NewsAnalyst ForecastAnalyst Revision0.33%RYTMRhythm Pharmaceuticals$64.84-3.8%4.1729 of 5 stars3.00$76.62 18.2%13Insider Trade0.32%SRPTSarepta Therapeutics$37.81-3.2%4.8209 of 5 stars2.87$122.61 224.3%230.31%PTCTPTC Therapeutics$50.82-1.8%4.3296 of 5 stars2.64$63.75 25.4%14Analyst Revision0.30%KRYSKrystal Biotech$139.62+1.0%4.6367 of 5 stars3.00$211.13 51.2%9Positive NewsAnalyst Revision0.30%MRUSMerus$55.05-2.5%3.2488 of 5 stars3.13$85.83 55.9%150.29%CYTKCytokinetics$33.11-4.1%4.4337 of 5 stars2.93$70.92 114.2%15Trending NewsAnalyst ForecastAnalyst Revision0.29%ACLXArcellx$66.17-0.7%2.8305 of 5 stars3.07$111.33 68.3%14Positive NewsInsider TradeAnalyst Revision0.28%ACADACADIA Pharmaceuticals$22.30+0.5%3.2197 of 5 stars2.69$26.79 20.1%16Trending NewsAnalyst Revision0.27%CRSPCRISPR Therapeutics$41.52-3.3%3.2912 of 5 stars2.50$71.75 72.8%18Analyst Revision0.27%SWTXSpringWorks Therapeutics$46.75+0.0%1.5843 of 5 stars2.13$52.57 12.5%8Positive News0.26%PTGXProtagonist Therapeutics$55.34-1.8%2.0077 of 5 stars3.00$65.44 18.3%9Analyst UpgradeInsider Trade0.26%RAREUltragenyx Pharmaceutical$37.514.2751 of 5 stars2.92$88.77 136.7%13Analyst Revision0.25%ALVOAlvotech$10.11-2.5%1.6867 of 5 stars3.00$18.00 78.0%2Short Interest ↑High Trading Volume0.25%SRRKScholar Rock$33.01-4.1%4.5209 of 5 stars3.14$42.67 29.3%7Positive News0.24%KYMRKymera Therapeutics$48.39-0.4%2.3065 of 5 stars3.00$59.82 23.6%180.23%CRNXCrinetics Pharmaceuticals$32.33-2.3%3.4006 of 5 stars2.91$74.56 130.6%11Positive NewsAnalyst Revision0.22%IMVTImmunovant$16.15-3.5%1.4501 of 5 stars2.90$38.33 137.4%10Positive NewsAnalyst Revision0.22%LEGNLegend Biotech$36.59-2.8%3.1066 of 5 stars2.91$76.20 108.3%11Trending NewsShort Interest ↑Analyst Revision0.19%XENEXenon Pharmaceuticals$32.26+0.3%3.4913 of 5 stars3.00$54.82 69.9%12Positive NewsAnalyst RevisionHigh Trading Volume0.18%AMRXAmneal Pharmaceuticals$7.78-0.4%3.7149 of 5 stars3.00$11.60 49.1%50.18%APLSApellis Pharmaceuticals$19.27-1.6%4.7091 of 5 stars2.62$40.05 107.8%21Analyst Revision0.18%BCRXBioCryst Pharmaceuticals$10.61-3.6%4.4187 of 5 stars2.89$16.56 56.0%9Positive NewsAnalyst Revision0.18%IBRXImmunityBio$3.24-3.0%2.2899 of 5 stars3.20$12.25 278.1%50.18%ZLABZai Lab$41.40+3.5%1.2951 of 5 stars2.75$47.37 14.4%4Analyst Revision0.17%MIRMMirum Pharmaceuticals$48.46-1.1%3.8483 of 5 stars3.17$60.73 25.3%12Analyst Revision0.17%NAMSNewAmsterdam Pharma$20.50-6.1%2.97 of 5 stars3.00$43.00 109.8%7Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.17%RXRXRecursion Pharmaceuticals$5.40-0.9%1.9404 of 5 stars2.33$7.60 40.7%6Trending NewsGap UpHigh Trading Volume0.17%VCELVericel$44.18-3.3%2.6568 of 5 stars3.00$61.14 38.4%7News CoveragePositive News0.16%DNLIDenali Therapeutics$15.19-0.5%4.3464 of 5 stars3.06$33.71 122.0%17Positive NewsAnalyst Revision0.16%CGONCG Oncology$26.18-4.7%2.4702 of 5 stars3.00$58.22 122.4%11Positive NewsAnalyst Revision0.16%ARWRArrowhead Pharmaceuticals$16.74-1.4%3.5429 of 5 stars2.75$43.71 161.1%8Analyst Revision0.16%HRMYHarmony Biosciences$35.14-2.0%4.7728 of 5 stars3.11$53.00 50.8%9Positive NewsShort Interest ↑Analyst Revision0.16%LGNDLigand Pharmaceuticals$115.39+1.7%4.5311 of 5 stars3.00$146.14 26.7%7News CoveragePositive News0.16%VCYTVeracyte$27.93+0.2%3.8872 of 5 stars2.70$40.90 46.4%100.15%AGIOAgios Pharmaceuticals$34.41-0.3%4.0248 of 5 stars2.63$56.50 64.2%8Positive NewsAnalyst Revision0.15%IDYAIDEAYA Biosciences$21.92-3.1%3.7969 of 5 stars2.93$54.27 147.6%14Positive NewsAnalyst Revision0.14%APGEApogee Therapeutics$42.44+1.0%2.1055 of 5 stars3.00$94.60 122.9%5High Trading Volume0.14%FOLDAmicus Therapeutics$6.14+0.5%3.9526 of 5 stars2.70$16.22 164.2%100.14%NVCRNovoCure$17.36-5.5%4.0599 of 5 stars2.67$32.83 89.1%60.14%SUPNSupernus Pharmaceuticals$33.15-0.3%1.6291 of 5 stars2.33$36.00 8.6%3Positive NewsHigh Trading Volume0.14%TWSTTwist Bioscience$35.15+2.0%4.2259 of 5 stars2.70$50.40 43.4%100.13%DYNDyne Therapeutics$14.57-1.4%2.4687 of 5 stars3.00$44.93 208.4%15Analyst Forecast0.13%ARQTArcutis Biotherapeutics$13.73-1.2%2.0556 of 5 stars2.83$18.80 36.9%6Gap Up0.13%INDVIndivior$13.66-0.2%2.6166 of 5 stars3.25$15.00 9.8%4Positive News0.13%IRONDisc Medicine$50.86-4.2%2.1911 of 5 stars3.09$96.70 90.1%11Positive NewsAnalyst ForecastInsider TradeAnalyst Revision0.13%TARSTarsus Pharmaceuticals$40.96-0.5%2.315 of 5 stars3.00$66.67 62.8%7Positive News0.12%BEAMBeam Therapeutics$17.89-1.1%3.0832 of 5 stars3.00$48.75 172.5%15Analyst Revision0.12%JANXJanux Therapeutics$25.46-3.0%2.2014 of 5 stars3.09$95.25 274.1%11Positive NewsAnalyst Revision0.11%ADPTAdaptive Biotechnologies$10.63+1.6%2.7086 of 5 stars2.83$9.83 -7.5%6Positive News0.11%EWTXEdgewise Therapeutics$15.75+1.9%2.8471 of 5 stars2.78$39.78 152.6%90.11%ETNB89bio$10.04-2.3%2.6543 of 5 stars3.00$26.43 163.2%8Analyst Revision0.11%IMCRImmunocore$35.56-1.0%2.9124 of 5 stars2.55$58.89 65.6%11Positive NewsAnalyst Revision0.11%OCULOcular Therapeutix$8.82-1.0%3.8674 of 5 stars2.88$16.25 84.2%8Positive NewsHigh Trading Volume0.11%SPRYARS Pharmaceuticals$14.34-2.4%3.4412 of 5 stars3.17$31.00 116.2%6Positive NewsAnalyst Revision0.11%VERAVera Therapeutics$22.10-2.3%2.8356 of 5 stars3.10$65.00 194.1%10Short Interest ↑Analyst RevisionGap Up0.10%GPCRStructure Therapeutics$22.72+4.1%2.2524 of 5 stars3.00$76.50 236.7%7News CoveragePositive NewsAnalyst Revision0.10%DVAXDynavax Technologies$10.18-2.4%4.1711 of 5 stars2.50$24.00 135.8%40.10%AMPHAmphastar Pharmaceuticals$26.05-3.2%3.6355 of 5 stars2.25$32.33 24.1%4 This page (NASDAQ:BIB) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIB Stock Free BIB Stock Alerts